- Company Overview for SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY (04343659)
- Filing history for SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY (04343659)
- People for SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY (04343659)
- Insolvency for SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY (04343659)
- Registers for SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY (04343659)
- More for SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY (04343659)
Persons with significant control: 1 person with significant control / 0 statements
Takeda Pharmaceutical Company Limited
- Correspondence address
- 1-1, Doshomachi 4-Chome, Chuo-Ku, Osaka, Japan
- Notified on
- 8 January 2019
- Governing law
- Legal form
- Kabushiki Kaisha (Or Stock Company)
- Place registered
- Registered With The Osaka Legal Affairs Bureau #
- Registration number
- 1200-01-077461
- Incorporated in
- Japan
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors
Shire Plc Ceased
- Correspondence address
- 22 Grenvill Street, Jersey, Jersey, JE4 8PX
- Notified on
- 6 April 2016
- Ceased on
- 8 January 2019
- Governing law
- Legal form
- Public Limited Company
- Place registered
- Jfsc Companies Registry
- Registration number
- 99854
- Incorporated in
- Jersey
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors